TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 1539845

Group type: EXPERIMENTAL
Intervention: Droperidol 0.075 mg/kg
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Metoclopramide 0.25 mg/kg
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Metoclopramide 0.15 mg/kg
Number of subjects: 110

Group type: COMPARATOR
Intervention: Saline control
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Droperidol
Number of subjects: 110
Study: 3577453

Group type: EXPERIMENTAL
Intervention: Vitaferro, Folicombin and additional vitamins
Number of subjects: 39
Study: 31652180

Group type: EXPERIMENTAL
Intervention: Video-assisted debriefing with trainees' errors (TE)
Number of subjects: 322

Group type: EXPERIMENTAL
Intervention: Video-assisted debriefing with simulated errors (SE)
Number of subjects: 322

Group type: COMPARATOR
Intervention: Control group (C)
Number of subjects: 322
Study: 29122125

Group type: EXPERIMENTAL
Intervention: Arthroscopically‐assisted reduction and internal fixation (ARIF)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Open reduction and internal fixation (ORIF)
Number of subjects: 75
Study: 25800242

Group type: EXPERIMENTAL
Intervention: Adenoma risk model developed from baseline data and logistic regression analysis.
Number of subjects: 1875

Group type: EXPERIMENTAL
Intervention: Baseline questionnaires on clinical risk factors and family history.
Number of subjects: 1875
Study: 23870606

Group type: EXPERIMENTAL
Intervention: Fluticasone/formoterol (100/10 µg BID)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluticasone (100 µg BID)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Formoterol (10 µg BID)
Number of subjects: 0
Study: 21655065

Group type: COMPARATOR
Intervention: OAC (omeprazole, amoxicillin, clarithromycin)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: OAL (omeprazole, amoxicillin, levofloxacin)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: OAL-R (omeprazole, amoxicillin, levofloxacin, rifaximin)
Number of subjects: 300
Study: 19508314

Group type: EXPERIMENTAL
Intervention: Gynecologic evaluation
Number of subjects: 949

Group type: COMPARATOR
Intervention: No gynecologic evaluation
Number of subjects: 949
Study: 16923483

Group type: EXPERIMENTAL
Intervention: 10 hours of unsupervised training on the GI Mentor
Number of subjects: 45

Group type: COMPARATOR
Intervention: No simulator experience
Number of subjects: 45
Study: 15225153

Group type: EXPERIMENTAL
Intervention: Standard antidepressant medication
Number of subjects: 12

Group type: COMPARATOR
Intervention: Spontaneous mania
Number of subjects: 12
Study: 11902552

Group type: EXPERIMENTAL
Intervention: Surgical management (lymph-node surgery)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Elective lymph-node dissection
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sentinel lymph-node biopsy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant nodal radiotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant radiotherapy after lymph-node dissection
Number of subjects: 0

Group type: COMPARATOR
Intervention: Systemic chemotherapy
Number of subjects: 0
Study: 9491554

Group type: EXPERIMENTAL
Intervention: Liquid chromatography-tandem mass spectrometry (LC-MS-MS)
Number of subjects: 0
Study: 7511751

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 3222045

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser iridotomy
Number of subjects: 20

Group type: COMPARATOR
Intervention: Pilocarpine (nonlaser-treated group)
Number of subjects: 20
Study: 1955900

Group type: EXPERIMENTAL
Intervention: Botulinum toxin 'A'
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Repeated toxin injections
Number of subjects: 20
Study: 1080438

Group type: EXPERIMENTAL
Intervention: Coronary bypass surgery
Number of subjects: 100

Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 100
Study: 27854117

Group type: EXPERIMENTAL
Intervention: PAV plus SIMV
Number of subjects: 46

Group type: COMPARATOR
Intervention: SIMV
Number of subjects: 46
Study: 30121728

Group type: EXPERIMENTAL
Intervention: Taking It to the Pews (TIPS) intervention
Number of subjects: 4

Group type: COMPARATOR
Intervention: Standard-information control arm
Number of subjects: 4
Study: 28646377

Group type: EXPERIMENTAL
Intervention: 1-month diabetes education program for community health workers (patients n=62)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Education course in other health issues for community health workers (patients n=56)
Number of subjects: 118
Study: 25958474

Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with a 637 nm GaAlAs laser, 40 mW, continuous wave, 6.26 J/cm2 per implant, applied daily for 7 days post-surgery
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both LLLT and control groups
Number of subjects: 12
Study: 23307315

Group type: COMPARATOR
Intervention: Medroxyprogesterone acetate (MPA) 10 mg BD for three cycles
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Aerial parts of wood betony (AWB) 5 g TDS for three months
Number of subjects: 66
Study: 22238738

Group type: EXPERIMENTAL
Intervention: 15 ml of 6% triphala mouthwash
Number of subjects: 57

Group type: COMPARATOR
Intervention: 15 ml of 0.2% chlorhexidine (active control)
Number of subjects: 57

Group type: COMPARATOR
Intervention: no mouthwash (passive control)
Number of subjects: 57
Study: 18991979

Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid (EPA) supplementation (500 mg/day)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61
Study: 16762346

Group type: EXPERIMENTAL
Intervention: Uterine artery ligation during cesarean section (group I)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Cesarean section only (group II)
Number of subjects: 48
Study: 15009104

Group type: EXPERIMENTAL
Intervention: Combination of calcipotriol ointment once daily and betamethasone dipropionate ointment once daily
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Calcipotriol monotherapy
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Betamethasone dipropionate monotherapy
Number of subjects: 7
Study: 11283119

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 488

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 488

Group type: EXPERIMENTAL
Intervention: Tamoxifen and Placebo
Number of subjects: 488
Study: 9542675

Group type: EXPERIMENTAL
Intervention: Oral itraconazole 200 mg twice daily for 7 days, followed by placebo for 7 days (n = 153)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Placebo in the morning and oral terbinafine 250 mg in the evening for 14 days (n = 151)
Number of subjects: 304
Study: 8117224

Group type: EXPERIMENTAL
Intervention: Ondansetron (8 mg oral dose)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 3403825

Group type: EXPERIMENTAL
Intervention: High dose dipyridamole-echocardiography test (0.84 mg/kg body weight over 10 min)
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Exercise-electrocardiography test
Number of subjects: 83
Study: 31212071

Group type: EXPERIMENTAL
Intervention: Indwelling Foley balloon catheter
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control group (without catheter placement)
Number of subjects: 70
Study: 29360920

Group type: EXPERIMENTAL
Intervention: Doxycycline + Vitamin K1 cream
Number of subjects: 126

Group type: COMPARATOR
Intervention: Doxycycline + Vehicle
Number of subjects: 126
Study: 27192695

Group type: EXPERIMENTAL
Intervention: n-3 PUFA-rich Inuit diet
Number of subjects: 233
Study: 25604761

Group type: EXPERIMENTAL
Intervention: Long-lasting insecticidal net screens (LLIS) with targeted treatment (TT) of breeding sites
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 1000
Study: 23754384

Group type: EXPERIMENTAL
Intervention: Postextinction administration of L-dopa
Number of subjects: 0
Study: 19261278

Group type: EXPERIMENTAL
Intervention: Low-dose aspirin treatment starting from the first day of controlled ovarian hyperstimulation in 1503 cycles
Number of subjects: 3154

Group type: COMPARATOR
Intervention: No treatment in the remaining 922 cycles
Number of subjects: 3154
Study: 19205092

Group type: EXPERIMENTAL
Intervention: Amlodipine 10 mg and Valsartan 160 mg
Number of subjects: 105

Group type: COMPARATOR
Intervention: Ramipril 5 mg and Felodipine 5 mg
Number of subjects: 105
Study: 17011843

Group type: EXPERIMENTAL
Intervention: Topical prednisolone and diclofenac (verum)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Lubricating eye drops (placebo)
Number of subjects: 32
Study: 14520619

Group type: EXPERIMENTAL
Intervention: Predialysis psychoeducational intervention (PPI)
Number of subjects: 297

Group type: COMPARATOR
Intervention: Usual-care control group
Number of subjects: 297
Study: 11889276

Group type: EXPERIMENTAL
Intervention: Standard behavioral group intervention and standard intervention supplemented with spiritual strategies
Number of subjects: 529

Group type: COMPARATOR
Intervention: Self-help strategies
Number of subjects: 529

Group type: EXPERIMENTAL
Intervention: Active intervention group (top decile for weight loss)
Number of subjects: 529
Study: 9596422

Group type: EXPERIMENTAL
Intervention: Continuous infusion of flumazenil at 0.5 mg/h for 5 hours (CI group)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (CIN)
Number of subjects: 100
Study: 8165850

Group type: EXPERIMENTAL
Intervention: Vi-Liq (25 micrograms)
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Vi-Lyoph (25 micrograms)
Number of subjects: 323

Group type: EXPERIMENTAL
Intervention: Booster dose of Vi-Liq (27 to 34 months after primary immunization)
Number of subjects: 323

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 323
Study: 3280097

Group type: EXPERIMENTAL
Intervention: Real time ultrasound
Number of subjects: 350

Group type: COMPARATOR
Intervention: Intravenous urography
Number of subjects: 350

Group type: EXPERIMENTAL
Intervention: Normal ultrasound
Number of subjects: 350
Study: 31254422

Group type: EXPERIMENTAL
Intervention: S-1 plus oxaliplatin (SOX)
Number of subjects: 663

Group type: EXPERIMENTAL
Intervention: S-1 plus cisplatin (CS)
Number of subjects: 663

Group type: EXPERIMENTAL
Intervention: S-1 in SOX
Number of subjects: 663

Group type: COMPARATOR
Intervention: Both SOX and CS
Number of subjects: 663
Study: 28031175

Group type: EXPERIMENTAL
Intervention: Cetuximab + FOLFOX
Number of subjects: 2559

Group type: COMPARATOR
Intervention: FOLFOX
Number of subjects: 2559
Study: 26021722

Group type: EXPERIMENTAL
Intervention: Low-dose capecitabine (1,000 mg/m² twice daily on days 1 to 14 of every 21 days)
Number of subjects: 926

Group type: COMPARATOR
Intervention: Approved-dose capecitabine (1,250 mg/m² twice daily on days 1 to 14 of every 21 days)
Number of subjects: 926
Study: 24136736

Group type: EXPERIMENTAL
Intervention: Magnitude-based multi-echo MRI for estimating hepatic proton density fat fraction (PDFF)
Number of subjects: 29
Study: 22759439

Group type: EXPERIMENTAL
Intervention: Individual counseling on diet and physical activity by a public health nurse, and two group counseling sessions until offspring's age of five years.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group recruited among families who visited the same clinics one year earlier.
Number of subjects: 0
Study: 19399649

Group type: EXPERIMENTAL
Intervention: Reverse postural test (RPT)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Healthy controls and primary hypertensives (after supine resting)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: Patients with APA
Number of subjects: 51
Study: 17325585

Group type: EXPERIMENTAL
Intervention: Sm‐EDTMP (37 MBq x kg)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Sr (150 MBq)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Both radionuclides
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Sm‐EDTMP and Sr
Number of subjects: 100
Study: 15380916

Group type: EXPERIMENTAL
Intervention: Glutamine enriched total parenteral nutrition
Number of subjects: 23

Group type: COMPARATOR
Intervention: Isonitrogenous control solution
Number of subjects: 23
Study: 11449622

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with ifosfamide 1.6 g/m2 (d 1-3) and carboplatin (AUC 4, d1) every three weeks, with 21 patients receiving amifostine 740 mg/m2 d1-3 followed by standard radiation therapy (50.4 Gy percutaneous and high-dose-rate-after-loading for 21 patients, 2 x 5 Gy).
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy with ifosfamide and carboplatin.
Number of subjects: 34
Study: 9793284

Group type: EXPERIMENTAL
Intervention: Electric toothbrush with orthodontic brush head
Number of subjects: 84

Group type: COMPARATOR
Intervention: Manual toothbrush
Number of subjects: 84
Study: 7657052

Group type: EXPERIMENTAL
Intervention: Sham feeding (sight and smell of a meal, no taste)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Intravenous glucose tolerance test (25 g glucose/4 min)
Number of subjects: 11
Study: 2708766

Group type: EXPERIMENTAL
Intervention: Flexible lens material (Dk 92)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Rigid lens material (Dk 60)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Eye patching
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Time (2-hour period)
Number of subjects: 11
Study: 765356

Group type: EXPERIMENTAL
Intervention: Marathon group 1
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Marathon group 2
Number of subjects: 0

Group type: COMPARATOR
Intervention: No-treatment control group
Number of subjects: 0
Study: 31291444

Group type: EXPERIMENTAL
Intervention: Educational program (Health Magic Box)
Number of subjects: 173

Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 173
Study: 28080126

Group type: EXPERIMENTAL
Intervention: College course on terrorism (treatment)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-listed students (control)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Treatment classes from universities across the United States (Study 2)
Number of subjects: 0
Study: 25772955

Group type: EXPERIMENTAL
Intervention: Simulator training (Group-A)
Number of subjects: 30

Group type: COMPARATOR
Intervention: No simulator training (Group-B)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Comparison between Group-A and Group-B
Number of subjects: 30
Study: 22591260

Group type: EXPERIMENTAL
Intervention: Diode laser gingivectomy (940‐nm diode laser, ezlase, Biolase Technology Inc) as an adjunct to nonsurgical periodontal treatment
Number of subjects: 30

Group type: COMPARATOR
Intervention: Nonsurgical periodontal treatment only
Number of subjects: 30
Study: 21367933

Group type: EXPERIMENTAL
Intervention: rosiglitazone (8 mg/d)
Number of subjects: 53

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 53
Study: 20032535

Group type: EXPERIMENTAL
Intervention: Novel antiviral agents
Number of subjects: 0
Study: 17233233

Group type: EXPERIMENTAL
Intervention: Stage-targeted physical activity intervention
Number of subjects: 207

Group type: COMPARATOR
Intervention: Low-sodium diet brochures (Control)
Number of subjects: 207
Study: 15035683

Group type: EXPERIMENTAL
Intervention: Soya milk (0.44 mg isoflavones/kg body weight)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Tempeh (0.44 mg isoflavones/kg body weight)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Textured vegetable protein (TVP) (0.44 mg isoflavones/kg body weight)
Number of subjects: 57
Study: 11506196

Group type: EXPERIMENTAL
Intervention: Dietary supplementation with Lactobacillus rhamnosus HN001
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Dietary supplementation with Bifidobacterium lactis HN019
Number of subjects: 27

Group type: COMPARATOR
Intervention: Dietary run-in of milk alone
Number of subjects: 27
Study: 9551030

Group type: EXPERIMENTAL
Intervention: Warfarin prescription by specialists
Number of subjects: 138

Group type: COMPARATOR
Intervention: Warfarin prescription by general practitioners
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Warfarin prescription for elderly females by specialists
Number of subjects: 138

Group type: COMPARATOR
Intervention: Warfarin prescription for elderly females by general practitioners
Number of subjects: 138

Group type: EXPERIMENTAL
Intervention: Warfarin prescription for elderly males by specialists
Number of subjects: 138

Group type: COMPARATOR
Intervention: Warfarin prescription for elderly males by general practitioners
Number of subjects: 138
Study: 9481962

Group type: EXPERIMENTAL
Intervention: Epinephrine with lidocaine
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Epinephrine without lidocaine
Number of subjects: 39
Study: 1782954

Group type: EXPERIMENTAL
Intervention: Warfarin withdrawal (sudden or gradual)
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Warfarin withdrawal
Number of subjects: 47
Study: 6784849

Group type: EXPERIMENTAL
Intervention: Radical mastectomy followed by adjuvant chemotherapy (CMF: cyclophosphamide, methotrexate, fluorouracil)
Number of subjects: 386

Group type: COMPARATOR
Intervention: Radical mastectomy
Number of subjects: 386
Study: 30326768

Group type: EXPERIMENTAL
Intervention: Community Health Consultation Offices for Seniors (CHCO) intervention
Number of subjects: 403

Group type: COMPARATOR
Intervention: Care as usual (control group)
Number of subjects: 403
Study: 30791944

Group type: EXPERIMENTAL
Intervention: Oxytocin-enhanced motivational interviewing group therapy (MIGT)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Placebo-enhanced motivational interviewing group therapy (MIGT)
Number of subjects: 50
Study: 27707943

Group type: EXPERIMENTAL
Intervention: Action observation training (watching video clips demonstrating four-staged ambulation training)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control group (watching video clips of different landscape pictures)
Number of subjects: 25
Study: 26024940

Group type: EXPERIMENTAL
Intervention: Oral Tranexamic Acid (TA)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Combined Oral Contraceptives (COC)
Number of subjects: 17
Study: 24418284

Group type: EXPERIMENTAL
Intervention: Low-dose dynamic CT with iterative reconstruction (ASIR) at 100 kV, 40% ASIR, 480 mg I/kg contrast
Number of subjects: 113

Group type: COMPARATOR
Intervention: Conventional dynamic CT without ASIR at 120 kV, 0% ASIR, 600 mg I/kg contrast
Number of subjects: 113
Study: 22559867

Group type: EXPERIMENTAL
Intervention: 0.005% latanoprost once daily
Number of subjects: 20

Group type: COMPARATOR
Intervention: 0.005% latanoprost once every other day
Number of subjects: 20
Study: 19952754

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 48
Study: 19113994

Group type: EXPERIMENTAL
Intervention: Standardised program of nurse home visiting
Number of subjects: 208
Study: 16134183

Group type: EXPERIMENTAL
Intervention: Electrothermal bipolar vessel sealing system (group B)
Number of subjects: 184

Group type: COMPARATOR
Intervention: Classic suture ligation technique (group A)
Number of subjects: 184
Study: 12208638

Group type: EXPERIMENTAL
Intervention: 1 Hz rTMS at 130% of the individual motor threshold (MT) applied continuously over the right PFC for 20 minutes
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo stimulation
Number of subjects: 8
Study: 10505156

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with cisplatin 100 mg/m2, bleomycin 15 U/m2, and 5-fluorouracil 1000 mg/m2/day for 1-3 cycles followed by radiotherapy.
Number of subjects: 33

Group type: COMPARATOR
Intervention: Induction chemotherapy with methotrexate 50 mg/m2 (1-6 weekly injections) followed by radiotherapy.
Number of subjects: 33

Group type: COMPARATOR
Intervention: Control group treated with radical surgery followed by radiotherapy.
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Induction chemotherapy with cisplatin, bleomycin, and 5-fluorouracil followed by radiotherapy.
Number of subjects: 33
Study: 8867255

Group type: EXPERIMENTAL
Intervention: Innocuous vibration
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Innocuous transcutaneous electrical nerve stimulation (TENS)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Innocuous warming of skin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noxious heating of skin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noxious chemical skin stimulation (using mustard oil)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mildly noxious constant current transdermal electrical stimulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Innocuous stimuli applied prior to histamine or mustard oil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Noxious stimuli applied 2 min after histamine or mustard oil challenge
Number of subjects: 0
Study: 1533167

Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia (TEA) with 0.375% bupivacaine plus sufentanil, 1:200,000 (5 micrograms/mL) and intraoperative GA with midazolam/N2O
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Thoracic epidural analgesia (TEA)
Number of subjects: 20

Group type: COMPARATOR
Intervention: General anesthesia (GA)
Number of subjects: 20
Study: 4083810

Group type: EXPERIMENTAL
Intervention: Traditional method of preoperative skin preparation (routine shaving with cetrimide and chlorhexidine in alcohol)
Number of subjects: 716

Group type: COMPARATOR
Intervention: Alternate method without preoperative shaving
Number of subjects: 716
Study: 31452950

Group type: EXPERIMENTAL
Intervention: Multicolored dental restoration
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 30
Study: 30188013

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (20 minutes a day for 6 weeks)
Number of subjects: 91

Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 91
Study: 23661044

Group type: EXPERIMENTAL
Intervention: Subconjunctival bevacizumab (2.5 mg/0.1 mL)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Topical MMC (0.2 mg/mL for 3 min)
Number of subjects: 42
Study: 25154822

Group type: EXPERIMENTAL
Intervention: Cetuximab plus cisplatin-radiation
Number of subjects: 891

Group type: COMPARATOR
Intervention: Cisplatin-radiation alone
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: p16-positive oropharyngeal carcinoma (OPC)
Number of subjects: 891

Group type: EXPERIMENTAL
Intervention: p16-negative oropharyngeal carcinoma (OPC)
Number of subjects: 891
Study: 21963316

Group type: EXPERIMENTAL
Intervention: Online parent-based intervention
Number of subjects: 558

Group type: COMPARATOR
Intervention: e-newsletter control group
Number of subjects: 558